Tempest Therapeutics (TPST) Non Operating Interest Expenses (2021 - 2025)
Tempest Therapeutics (TPST) posted Non Operating Interest Expenses of $207,000 for FY2025, down 84.3% from $1.32 million in FY2024.
Powered by 
Analysis
Tempest Therapeutics (TPST) Non Operating Interest Expenses (2021 - 2025) Analysis & Trends
Since FY2017, Tempest Therapeutics has reported Non Operating Interest Expenses for 7 years.
- Annual Non Operating Interest Expenses has declined for three consecutive years, with a four-year compound annual growth rate of -36.6% (FY2021 to FY2025).
- The FY2025 figure stands as the lowest annual Non Operating Interest Expenses since FY2018.
- Business Quant data shows TPST's Non Operating Interest Expenses at $1.32 million in FY2024 (-9.2%), $1.45 million in FY2023 (-10.4%), $1.62 million in FY2022 (+26.2%) and $1.28 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | - |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | - |
| 10 | Tempest Therapeutics | 8.07 Mn | -22.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Dec 31, 2024 | 247,000.00 |
| Sep 30, 2024 | 329,000.00 |
| Jun 30, 2024 | 372,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 377,000.00 |
| Sep 30, 2023 | 373,000.00 |
| Jun 30, 2023 | 355,000.00 |
| Mar 31, 2023 | 344,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 389,000.00 |
| Jun 30, 2022 | 464,000.00 |
| Mar 31, 2022 | 333,000.00 |
| Dec 31, 2021 | 338,000.00 |
| Sep 30, 2021 | 437,000.00 |
| Jun 30, 2021 | 276,000.00 |
| Mar 31, 2021 | 231,000.00 |
API Access
Tempest Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();